How have LHDXQ shares performed in 2024?

Lucira Health's stock was trading at $0.0001 at the beginning of 2024. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here .

How were Lucira Health's earnings last quarter?

Lucira Health, Inc. (OTCMKTS:LHDXQ) released its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.51) by $0.04. The company had revenue of $14.98 million for the quarter, compared to analyst estimates of $18 million.

How do I buy shares of Lucira Health?

Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:LHDXQ

Lucira Health (LHDXQ) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free LHDXQ Stock Alerts

$0.0001

+0.00 (+∞)

(As of 10/4/2023)

Compare

Today's Range: $0.0001
▼
$0.0001
50-Day Range: N/A
52-Week Range: $0.00
▼
$1.45

Volume: 20,900 shs
Average Volume: 7.18 million shs
Market Capitalization: $4,060.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Insider Trades

Get Lucira Health alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Lucira Health Stock (OTCMKTS:LHDXQ)

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

LHDXQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LHDXQ Stock News Headlines

September 20, 2023 | msn.com

U.S. govt. to restart program to ship free at-home COVID tests

August 3, 2023 | forbes.com

Best Senior Dating Sites Of 2023

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 28, 2023 | benzinga.com

Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid

April 20, 2023 | marketwatch.com

8-K: Lucira Health, Inc.

April 11, 2023 | bizjournals.com

Bankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to Pfizer

April 7, 2023 | bizjournals.com

Pfizer to buy Covid-flu test developer Lucira Health out of bankruptcy court

April 6, 2023 | wsj.com

Firm Retention Summary: Lucira Health Inc.

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

March 29, 2023 | marketwatch.com

Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process

March 20, 2023 | investing.com

Lucira Health Inc (LHDXQ)

March 18, 2023 | finance.yahoo.com

FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test

March 17, 2023 | seekingalpha.com

LHDXQ Lucira Health, Inc.

March 10, 2023 | finance.yahoo.com

FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test

March 8, 2023 | bizjournals.com

Covid-flu test fell short of number of flu samples, FDA says in explaining delay

March 8, 2023 | bizjournals.com

FDA fires back at claims of long delay in approving combined Covid-flu test

March 7, 2023 | finance.yahoo.com

UPDATE 1-Lucira's home test for flu and COVID-19 gets U.S. FDA nod for OTC use

March 7, 2023 | finance.yahoo.com

FDA Approval Brings Some Good News For Bankrupt Lucira Health

March 3, 2023 | investorplace.com

Why Is Lucira Health (LHDX) Stock Down 14% Today?

February 28, 2023 | benzinga.com

Short Volatility Alert: Lucira Health Inc

February 28, 2023 | msn.com

Lucira Soars on FDA Approval of COVID-19 and Flu Test

February 27, 2023 | finance.yahoo.com

Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing

February 27, 2023 | msn.com

Lucira Health is Soaring Monday: Here Are The Details

February 27, 2023 | rttnews.com

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

February 24, 2023 | bizjournals.com

Delay with Covid-flu test sent East Bay company to Chapter 11. Regulators OK it — two days later

February 24, 2023 | finance.yahoo.com

Lucira stock more than doubles after hours on FDA OK for COVID-19, flu test

February 24, 2023 | seekingalpha.com

Lucira Health to sell business and file Chapter 11 bankruptcy; shares down 7%

See More Headlines

Receive LHDXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostic substances
Sub-Industry: N/A
Current Symbol: OTCMKTS:LHDXQ
CUSIP: N/A
CIK: 1652724
Web: www.lucirahealth.com
Phone: 510-350-8071
Fax: N/A
Employees: 221
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $93.06 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.81 per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 40,600,000
Free Float: 28,257,000
Market Cap: $4,060.00
Optionable: Not Optionable
Beta: 2.60

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Greg Chodaczek
Investor Relations
Dr. Nadine Greiner Ph.D.
Chief HR Officer

Key Competitors

View All Competitors

LHDXQ Stock Analysis - Frequently Asked Questions

How have LHDXQ shares performed in 2024?: Lucira Health's stock was trading at $0.0001 at the beginning of 2024. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here.
How were Lucira Health's earnings last quarter?: Lucira Health, Inc. (OTCMKTS:LHDXQ) released its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.51) by $0.04. The company had revenue of $14.98 million for the quarter, compared to analyst estimates of $18 million.
How do I buy shares of Lucira Health?: Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LHDXQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial